Concepedia

Publication | Closed Access

Intravesical bacillus calmette-gueÈrin for the treatment of superficial bladder cancer in renal transplant patients

83

Citations

6

References

2003

Year

Abstract

Intravesical BCG in superficial bladder cancer and/or CIS is a valid option, with no added morbidity to renal transplant patients.

References

YearCitations

Page 1